| WallStreetSignals.com | The Largest Stock Market "SCORING" Source on the Internet . . | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Stock Scores . . . | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| What is on this Page : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| We have listed for your review…all the Stocks in the " Drug " Industry in the order of their current " SCORE ". Also listed are their current " Value " and current " Price " along with all the most relevant Fundamental and Technical Data needed to evaluate each Stock. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| How to Use this Data : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Every day multiple data points are updated and submitted to formulas that generate each Stock's current "Score" and "Value" so that you can see if the Stock's current situation is "Favorable" or "Un-Favorable" in today's Market. Look across the row of data for each Stock to determine "Favorable" or "Un-Favorable" columns of Data highlighted in Green, Yellow or Red. | WallStreetSignals.com | The Largest Stock Market "SCORING" Source on the Internet . . | WallStreetSignals.com | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Why each Stock's calculated "Value" is useful : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Our formulas use daily data to generate each Stock's current "Value" expressed in it's Price. Look in the "Value" column compared to the Stock's Recent "Price" column. A Stock with a current "Value" ABOVE it's Price is considered "Favorable" while a Stock with a "Value" UNDER it's Price is "Un-Favorable". | Drug Stock Scores . . . | Drug Stock Scores . . . | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GREEN = Favorable | YELLOW = Neutral | RED = Un-Favorable | More Data | u | GREEN - Favorable | YELLOW = Neutral | RED = Un-Favorable | More Data | u | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| September 2009 | Rate Of Return | Earnings Per Share | "P / E " Ratio | Earnings Growth Rate | Sales Growth Rate | Current Price ABOVE… | Current Volume ABOVE… | Dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock RANK | Symbol | Stock | Industry | Recent Price | Total SCORE | Volume | Stock's Current "Value" | Stock's Current "Value" ABOVE Current Price | Last 1 Day | Latest Week | Latest 30 Days | YTD 2009 | 2008 | Symbol | 12 Month Earnings per Share Forecast on 12/31/08 | 12 Month Earnings per Share Forecast on 3/31/09 | 12 Month Earnings per Share Forecast on 6/30/09 | Today's 12 Month Earnings per Share Forecast | Change in 12 Month Earnings per Share Forecast from last year. | This Stock's "P/E" | The Average "P/E" of all Stocks in the same Industry | 12/31/08 | Today | % Change - Today vs. Last Year | 12/31/08 | Today | % Change - Today vs. Last Year | 5 Day Moving Average | 10 Day Moving Average | 20 Day Moving Average | 100 Day Moving Average | 200 Day Moving Average | Symbol | 5 Day Moving Average | 10 Day Moving Average | 20 Day Moving Average | Total $ Amount Paid Last Year | Total $ Amount for 2009 Estimated | % Increase This Year vs. Last Year | Current Dividend Yield Based on Current Price | ||||||||||||||||||||||||||||||||||||||||||||
| DJIA ( DIA ) For Same Period : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 0% | 4% | 3% | 10% | -34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S & P 500 ( SPY ) For Same Period : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 0% | 5% | 4% | 16% | -38% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Industry Average For Same Period : | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 0% | 6% | 8% | 29% | -35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Note # 1 | [ Please view the Notes at the bottom of this Page ] | Note # 2 | Note # 3 | Note # 4 | Note # 5 | Note # 6 | Note # 7 | Note # 8 | Note # 9 | Note # 10 | Note # 11 | Note # 12 | Note # 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Stocks - Listed in Stock's "Total Score" Rank ( Includes Biomedical, Genetic, Ethical, Generic & Wholescale Distribution ) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | SNY | Sanofi-Aventis | Drug (Ethical) | $ 35.05 | 87% | 2,273,257 | $ 53.42 | 52% | 0% | 5% | 7% | 9% | -29% | SNY | 6.41 | 2.83 | 3.59 | 4.07 | -37% | 9 | 22 | 15% | 7% | -53% | -3% | 4% | 233% | 5% | 3% | 3% | 18% | 18% | SNY | 189% | 173% | 102% | $1.63 | $1.42 | -13% | 4% | ||||||||||||||||||||||||||||||||||||||||||||
| 23 | HITK | Hi-Tech Pharm | Drug (Generic) | $ 20.31 | 80% | 1,588,367 | $ 34.73 | 71% | -9% | 39% | 41% | 267% | -43% | HITK | 0.36 | 0.48 | 0.56 | 0.88 | 144% | 23 | 14 | 32% | 37% | 16% | 34% | 75% | 121% | 34% | 24% | 14% | 125% | 164% | HITK | 100% | 213% | 355% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 36 | INHX | Inhibitex Inc | Drug (Biomedical\Genetic) | $ 1.18 | 77% | 1,345,028 | $ 0.60 | -49% | 1% | 115% | 168% | 352% | -67% | INHX | -0.42 | -0.34 | -0.36 | -0.40 | 5% | -3 | -12 | -8% | 8% | 200% | 19% | -29% | -253% | 110% | 77% | 57% | 231% | 260% | INHX | 113% | 195% | 435% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 54 | CYTR | Cytrx Corp | Drug (Biomedical\Genetic) | $ 1.23 | 74% | 8,034,005 | $ 0.12 | -90% | 14% | 31% | 29% | 310% | -89% | CYTR | -0.25 | -0.27 | -0.24 | -0.15 | 40% | -8 | -12 | 10% | 5% | -50% | -12% | -36% | -200% | 29% | 25% | 24% | 83% | 125% | CYTR | 400% | 490% | 503% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 70 | BHRT | Bioheart Inc | Drug (Biomedical\Genetic) | $ 1.44 | 71% | 80,023 | $ 0.09 | -94% | 97% | 136% | 89% | 45% | BHRT | -1.23 | -1.37 | -0.79 | 49% | -2 | -12 | 16% | 8% | -50% | -6% | 0% | 0% | 108% | 120% | 112% | 83% | 27% | BHRT | 227% | 136% | 128% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||||
| 122 | PCYC | Pharmacyclics | Drug (Biomedical\Genetic) | $ 1.70 | 67% | 339,367 | $ 0.12 | -93% | 17% | 30% | 19% | 115% | -46% | PCYC | -0.64 | -0.78 | -0.75 | -0.60 | 6% | -3 | -12 | -4% | -1% | 75% | -100% | 0% | 0% | 28% | 28% | 23% | 35% | 48% | PCYC | 673% | 663% | 360% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 126 | PRX | Par Pharma | Drug (Generic) | $ 21.65 | 66% | 294,176 | $ 34.57 | 60% | 1% | 6% | 33% | 61% | -44% | PRX | 0.95 | -0.37 | 0.43 | 1.01 | 6% | 21 | 14 | -5% | 23% | 560% | -28% | 44% | 257% | 9% | 4% | 4% | 63% | 68% | PRX | -55% | -52% | -64% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 151 | AVGN | Avigen Inc | Drug (Biomedical\Genetic) | $ 1.54 | 65% | 374,576 | $ 1.14 | -26% | 8% | 19% | 15% | 103% | -82% | AVGN | -1.13 | -0.87 | -0.87 | -0.66 | 42% | -2 | -12 | -7% | -6% | 14% | -100% | 0% | 0% | 17% | 18% | 16% | 22% | 39% | AVGN | 172% | 184% | 214% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 182 | NPSP | N P S Pharm | Drug (Biomedical\Genetic) | $ 4.81 | 64% | 491,747 | $ 0.39 | -92% | 2% | 16% | 6% | -23% | 62% | NPSP | -0.59 | -0.6 | -0.58 | -0.41 | 31% | -12 | -12 | -7% | -7% | 0% | 47% | -20% | -143% | 10% | 11% | 10% | 17% | -2% | NPSP | 126% | 131% | 75% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 190 | BVF | Biovail Corp | Drug (Ethical) | $ 13.06 | 63% | 778,959 | $ 23.36 | 79% | 0% | 6% | -6% | 38% | -30% | BVF | 1.13 | 1.23 | 1.43 | 1.43 | 27% | 9 | 22 | -7% | 10% | 243% | -18% | -7% | 61% | -1% | 3% | 3% | 7% | 14% | BVF | -13% | -26% | -22% | $1.50 | $0.36 | -76% | 3% | ||||||||||||||||||||||||||||||||||||||||||||
| 262 | DSCO | Discovery Labs | Drug (Biomedical\Genetic) | $ 0.86 | 60% | 50,953,642 | $ 0.08 | -91% | 79% | 79% | 79% | -23% | -48% | DSCO | -0.54 | -0.44 | -0.41 | -0.45 | 17% | -2 | -12 | -7% | -6% | 14% | -100% | -99% | 1% | 75% | 76% | 78% | -16% | -22% | DSCO | 1000% | 1000% | 1000% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 297 | AVNR | Avanir Pharm A | Drug (Biomedical\Genetic) | $ 2.21 | 59% | 4,920,203 | $ 0.26 | -88% | 11% | 16% | -11% | 439% | -68% | AVNR | -0.23 | -0.23 | -0.2 | -0.24 | -4% | -9 | -12 | 14% | 13% | -7% | -25% | -50% | -100% | 9% | 13% | 13% | 66% | 123% | AVNR | 518% | 230% | 84% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 374 | PSDV | Psivida Ltd | Drug (Biomedical\Genetic) | $ 3.59 | 57% | 134,419 | $ 1.36 | -62% | 5% | 24% | 41% | 282% | -70% | PSDV | -4.37 | -3.96 | -3.38 | -3.26 | 25% | -1 | -12 | -6% | 9% | 250% | 307% | 983% | 220% | 39% | 26% | 16% | 117% | 159% | PSDV | 31% | 121% | 218% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 378 | CRXL | Crucell NV ADR | Drug (Biomedical\Genetic) | $ 23.80 | 57% | 492,910 | $ 26.78 | 13% | 4% | 8% | -1% | 57% | -8% | CRXL | 0.59 | 0.36 | 0.56 | 0.70 | 19% | 34 | -12 | 41% | 40% | -2% | 42% | 33% | -21% | 5% | 8% | 7% | 7% | 18% | CRXL | 18% | 71% | 108% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 386 | CYTK | Cytokinetics | Drug (Biomedical\Genetic) | $ 3.34 | 57% | 217,463 | $ 2.63 | -21% | 0% | 6% | 14% | 17% | -40% | CYTK | -0.65 | -0.98 | -0.65 | -0.32 | 51% | -10 | -12 | 14% | 18% | 29% | 16% | 507% | 3069% | 10% | 6% | 4% | 42% | 42% | CYTK | -21% | -36% | -18% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 409 | FMTI | Forbes MedTech | Drug (Ethical) | $ 0.37 | 57% | 48,612 | $ 0.51 | 38% | -8% | 19% | 28% | 95% | -91% | FMTI | -1.64 | -1.56 | -0.56 | -0.11 | 93% | -3 | 22 | -6% | 12% | 300% | 4% | -49% | -1325% | 13% | 10% | 1% | 20% | 40% | FMTI | 23% | 112% | 184% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 421 | NGSX | Neurogesx Inc | Drug (Ethical) | $ 7.73 | 56% | 404,574 | $ 0.81 | -90% | 0% | 2% | 5% | 561% | -82% | NGSX | -1.33 | -1.29 | -1.26 | -1.26 | 5% | -6 | 22 | 6% | 7% | 17% | 0% | 0% | 0% | 4% | 2% | 1% | 58% | 121% | NGSX | 781% | 843% | 629% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 452 | PSSI | P S S World | Drug (Wholesale\Distrb) | $ 21.22 | 56% | 606,880 | $ 36.78 | 73% | -1% | 2% | 5% | 13% | -4% | PSSI | 0.95 | 1.07 | 1.08 | 1.13 | 19% | 19 | 19 | 0% | 13% | 0% | 7% | 4% | -43% | 4% | 2% | 0% | 28% | 27% | PSSI | 51% | -3% | 23% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 468 | CVM | Cel-Sci Corp | Drug (Biomedical\Genetic) | $ 0.79 | 55% | 7,744,803 | $ 0.10 | -87% | -1% | 18% | 65% | 177% | -44% | CVM | -0.06 | -0.06 | -0.06 | -0.08 | -33% | -10 | -12 | 6% | 16% | 167% | -86% | 394% | 558% | 36% | 15% | 13% | 120% | 149% | CVM | 47% | -18% | 31% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 471 | SLXP | Salix Pharm | Drug (Ethical) | $ 13.38 | 55% | 820,171 | $ 7.61 | -43% | -3% | 10% | 7% | 52% | 12% | SLXP | -0.35 | -0.48 | -0.15 | -0.11 | 69% | -122 | 22 | -13% | 35% | 369% | -39% | 10% | 126% | 5% | 5% | 4% | 31% | 40% | SLXP | 44% | 110% | 106% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 476 | VRX | Valeant Pharm | Drug (Ethical) | $ 26.41 | 55% | 588,145 | $ 45.85 | 74% | -2% | 3% | -3% | 15% | 91% | VRX | 0.99 | -0.82 | 0.48 | 1.25 | 26% | 21 | 22 | 0% | 37% | 0% | 13% | 9% | -31% | 0% | 2% | 1% | 23% | 25% | VRX | 23% | 0% | -31% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 484 | EXAS | EXACT Sciences | Drug (Biomedical\Genetic) | $ 2.94 | 55% | 174,876 | $ 0.23 | -92% | 4% | 31% | 6% | 416% | -82% | EXAS | -0.46 | -0.45 | -0.4 | -0.39 | 15% | -8 | -12 | -8% | 1% | 113% | -100% | 0% | 0% | 21% | 23% | 16% | 50% | 86% | EXAS | 99% | 107% | 88% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 535 | ORXE | Ore Pharma | Drug (Biomedical\Genetic) | $ 0.78 | 54% | 36,919 | $ 0.63 | -19% | 5% | 42% | 33% | 63% | -88% | ORXE | -4.09 | -4.1 | -2.49 | -1.91 | 53% | 0 | -12 | -6% | -6% | 0% | -100% | -93% | 7% | 31% | 29% | 21% | 53% | 49% | ORXE | -54% | -20% | 45% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 536 | NVO | Novo NordskADR | Drug (Ethical) | $ 63.62 | 54% | 151,754 | $ 129.36 | 103% | 0% | 6% | 7% | 24% | -21% | NVO | 3.08 | 3.12 | 3.44 | 3.81 | 24% | 17 | 22 | 10% | 18% | 80% | 7% | 14% | 100% | 4% | 4% | 3% | 24% | 23% | NVO | 8% | 7% | -8% | $0.84 | $1.09 | 30% | 2% | ||||||||||||||||||||||||||||||||||||||||||||
| 553 | QLTI | Q L T Inc | Drug (Biomedical\Genetic) | $ 4.28 | 54% | 406,956 | $ 8.40 | 96% | -1% | 2% | 7% | 78% | -45% | QLTI | 0.06 | 0.18 | 0.27 | 0.24 | 300% | 18 | -12 | -10% | 34% | 440% | 19% | -11% | -158% | 3% | 1% | 0% | 81% | 87% | QLTI | 61% | 17% | -7% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 574 | QGEN | Qiagen NV | Drug (Biomedical\Genetic) | $ 21.31 | 53% | 660,687 | $ 37.17 | 74% | 1% | 5% | 6% | 21% | -17% | QGEN | 0.96 | 0.69 | 0.83 | 0.91 | -5% | 23 | -12 | 20% | 20% | 0% | 30% | 14% | -53% | 3% | 4% | 3% | 23% | 25% | QGEN | 20% | 14% | -22% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 590 | OPXA | Opexa Thera | Drug (Biomedical\Genetic) | $ 4.10 | 53% | 7,626,227 | $ 0.07 | -98% | -4% | 211% | 138% | 2058% | -92% | OPXA | -1.01 | -1.52 | -0.91 | -0.66 | 35% | -6 | -12 | 9% | -6% | -167% | 0% | 0% | 0% | 142% | 108% | 63% | 688% | 866% | OPXA | 28% | 148% | 328% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 594 | ADLS | AdvancedLifeSci | Drug (Biomedical\Genetic) | $ 0.27 | 53% | 4,841,660 | $ 0.05 | -81% | 23% | 23% | 20% | -25% | -79% | ADLS | -0.4 | -0.39 | -0.26 | -0.20 | 50% | -1 | -12 | 7% | 14% | 100% | -100% | 0% | 0% | 26% | 28% | 24% | -49% | -38% | ADLS | 497% | 320% | 279% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 607 | HGSI | Human Genome | Drug (Biomedical\Genetic) | $ 19.22 | 53% | 3,527,114 | $ 1.50 | -92% | -2% | 10% | 19% | 807% | -80% | HGSI | -0.92 | -1.55 | -0.92 | -0.59 | 36% | -33 | -12 | -7% | 18% | 357% | 22% | 382% | 1636% | 8% | 0% | 2% | 348% | 452% | HGSI | -50% | -71% | -65% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 613 | PTN | Palatin Tech | Drug (Biomedical\Genetic) | $ 0.37 | 53% | 1,864,696 | $ 0.03 | -92% | 9% | 21% | 16% | 311% | -55% | PTN | -0.11 | -0.16 | -0.1 | -0.11 | 0% | -3 | -12 | 5% | -4% | -180% | -22% | -38% | -73% | 15% | 15% | 14% | 76% | 125% | PTN | 197% | 314% | 100% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 620 | CRME | Cardiome Pharma | Drug (Ethical) | $ 4.45 | 52% | 525,869 | $ 3.38 | -24% | -2% | 3% | 14% | -2% | -49% | CRME | -0.38 | -0.82 | -0.12 | 0.10 | 126% | 45 | 22 | -6% | 33% | 650% | -85% | 259% | 405% | 5% | 0% | 1% | 17% | 8% | CRME | 5% | -19% | -11% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 690 | SCLN | Sciclone Pharm | Drug (Biomedical\Genetic) | $ 4.83 | 51% | 554,585 | $ 6.72 | 39% | -4% | 1% | 22% | 553% | -64% | SCLN | 0.12 | -0.16 | 0.09 | 0.18 | 50% | 27 | -12 | 25% | 38% | 52% | 37% | 52% | 41% | 10% | 1% | -2% | 115% | 177% | SCLN | -8% | -54% | -34% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 714 | MWIV | MWI Veterinary | Drug (Wholesale\Distrb) | $ 39.84 | 51% | 32,926 | $ 54.96 | 38% | -2% | 2% | 1% | 48% | -33% | MWIV | 1.79 | 1.86 | 1.98 | 2.11 | 18% | 19 | 19 | 9% | 13% | 44% | 17% | 15% | -12% | 0% | 1% | 0% | 25% | 34% | MWIV | -12% | -27% | -32% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 724 | ENDP | Endo Pharm | Drug (Ethical) | $ 22.95 | 50% | 1,308,339 | $ 40.91 | 78% | 0% | 5% | 7% | -11% | -3% | ENDP | 2.6 | 2.43 | 2.56 | 2.63 | 1% | 9 | 22 | 17% | 14% | -18% | 17% | 17% | 0% | 4% | 2% | 3% | 29% | 18% | ENDP | -39% | -36% | -30% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 759 | RPTP | Raptor Pharma | Drug (Biomedical\Genetic) | $ 0.55 | 50% | 99,262 | $ 0.06 | -89% | 10% | 4% | 62% | 323% | -78% | RPTP | -0.2 | -0.2 | -0.17 | -0.15 | 25% | -4 | -12 | -6% | 18% | 400% | 0% | 0% | 0% | 36% | 14% | 7% | 91% | 118% | RPTP | 95% | -59% | -40% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 783 | VICL | Vical Inc. | Drug (Biomedical\Genetic) | $ 5.12 | 50% | 1,564,918 | $ 1.31 | -74% | -4% | 16% | 45% | 263% | -67% | VICL | -0.87 | -0.78 | -0.73 | -0.61 | 30% | -8 | -12 | -5% | 9% | 280% | 1% | 72% | 7100% | 25% | 9% | 4% | 105% | 137% | VICL | -53% | -40% | -3% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 787 | PPCO | Penwest Pharma | Drug (Biomedical\Genetic) | $ 2.49 | 49% | 68,485 | $ 6.08 | 144% | 3% | 4% | -2% | 59% | -73% | PPCO | -0.31 | -0.24 | 0.29 | 0.52 | 268% | 5 | -12 | 14% | 51% | 264% | 35% | 347% | 891% | 3% | 2% | 4% | 14% | 28% | PPCO | 252% | 135% | 75% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 795 | CHDX | Chindex Int'l | Drug (Wholesale\Distrb) | $ 13.36 | 49% | 106,710 | $ 11.65 | -13% | -3% | 8% | -11% | 68% | -65% | CHDX | 0.45 | 0.24 | 0.5 | 0.62 | 38% | 22 | 19 | 7% | -5% | -171% | 16% | 36% | 125% | -3% | 0% | 3% | 42% | 62% | CHDX | -41% | -44% | -49% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 809 | VNDA | Vanda Pharma | Drug (Biomedical\Genetic) | $ 14.26 | 49% | 1,638,300 | $ 1.55 | -89% | -6% | 11% | 2% | 2752% | -93% | VNDA | -1.23 | -1.4 | -1.83 | -1.00 | 19% | -14 | -12 | 10% | 8% | -20% | 0% | 0% | 0% | 4% | 3% | 6% | 69% | 163% | VNDA | 111% | 149% | 205% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 854 | DCGN | deCODE genetic | Drug (Biomedical\Genetic) | $ 0.53 | 49% | 1,192,702 | $ 0.05 | -90% | -8% | 9% | -13% | 184% | -95% | DCGN | -1.19 | -1.4 | -1.14 | -1.05 | 12% | -1 | -12 | -2% | -6% | -200% | 44% | 12% | -73% | -4% | -2% | 0% | 38% | 65% | DCGN | 169% | 169% | 179% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 855 | GILD | Gilead Science | Drug (Biomedical\Genetic) | $ 46.10 | 49% | 7,396,277 | $ 107.42 | 133% | -1% | 2% | 1% | -10% | 11% | GILD | 2.39 | 2.42 | 2.64 | 2.80 | 17% | 16 | -12 | 21% | 21% | 0% | 24% | 27% | 13% | 1% | 1% | 0% | 2% | 0% | GILD | 11% | 16% | 10% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 887 | DYAX | Dyax Corp | Drug (Biomedical\Genetic) | $ 4.11 | 48% | 339,885 | $ 0.34 | -92% | 6% | 17% | 9% | 13% | -1% | DYAX | -0.75 | -0.82 | -0.84 | -0.74 | 1% | -6 | -12 | 15% | 5% | -67% | 172% | 75% | -56% | 13% | 13% | 12% | 66% | 56% | DYAX | 27% | 29% | 66% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 910 | WPI | Watson Pharm | Drug (Generic) | $ 36.43 | 48% | 577,428 | $ 67.75 | 86% | 0% | 5% | 5% | 37% | -2% | WPI | 2.05 | 2.31 | 2.41 | 2.53 | 23% | 14 | 14 | 18% | 17% | -6% | 1% | 6% | 500% | 4% | 3% | 3% | 16% | 23% | WPI | -43% | -39% | -36% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 914 | UPBS | Upstream Bio | Drug (Biomedical\Genetic) | $ 0.02 | 48% | 32,200 | $ 0.01 | 0% | -26% | -43% | 15% | -83% | UPBS | -0.05 | -0.05 | -0.04 | -0.03 | 40% | -1 | -12 | -1% | 9% | 1000% | 0% | 0% | 0% | -12% | 14% | 271% | -52% | -60% | UPBS | 1000% | 404% | -3% | $0.00 | $0.00 | 0% | 0% | |||||||||||||||||||||||||||||||||||||||||||||
| 948 | FRX | Forest Labs | Drug (Ethical) | $ 29.09 | 47% | 2,863,534 | $ 41.12 | 41% | -2% | 3% | 6% | 14% | -30% | FRX | 3.26 | 3.06 | 3.17 | 3.29 | 1% | 9 | 22 | 2% | 3% | 50% | 9% | 3% | -67% | 2% | 1% | 1% | 23% | 22% | FRX | 17% | 28% | 27% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1002 | TAROF | Taro Pham Inds | Drug (Generic) | $ 9.20 | 47% | 13,000 | $ 21.10 | 129% | 1% | 1% | 1% | 19% | 1% | TAROF | 0.96 | 1.42 | 1.69 | 1.74 | 81% | 5 | 14 | -5% | 32% | 740% | 70% | 9% | -87% | 1% | 1% | 1% | 4% | 4% | TAROF | -1% | -38% | -43% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1038 | HSP | Hospira Inc | Drug (Biomedical\Genetic) | $ 40.82 | 47% | 696,299 | $ 83.59 | 105% | 0% | 4% | 2% | 52% | -37% | HSP | 2.77 | 2.38 | 2.9 | 3.03 | 9% | 13 | -12 | 18% | 21% | 17% | 15% | 2% | -87% | 3% | 3% | 3% | 20% | 31% | HSP | -14% | -11% | -9% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1090 | CEPH | Cephalon | Drug (Ethical) | $ 58.78 | 46% | 866,245 | $ 134.19 | 128% | 0% | 5% | 3% | -24% | 7% | CEPH | 5.66 | 4.68 | 5.48 | 5.84 | 3% | 10 | 22 | 20% | 29% | 45% | 4% | 15% | 275% | 4% | 3% | 3% | -4% | -11% | CEPH | -54% | -53% | -43% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1093 | AFFX | Affymetrix Inc | Drug (Biomedical\Genetic) | $ 8.28 | 46% | 1,523,413 | $ 3.60 | -57% | -5% | 1% | -10% | 177% | -87% | AFFX | -0.29 | -2.77 | -2.1 | -1.38 | -376% | -6 | -12 | -9% | -9% | 0% | 19% | -32% | -268% | -2% | 0% | -3% | 57% | 87% | AFFX | 83% | 60% | 53% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1099 | IMMU | Immunomedics | Drug (Biomedical\Genetic) | $ 6.08 | 46% | 1,176,533 | $ 0.58 | -90% | -4% | 0% | 53% | 258% | -27% | IMMU | -0.06 | -0.21 | -0.08 | 0.01 | 117% | -12 | 19% | 33% | 74% | 527% | 722% | 37% | 21% | 2% | -3% | 173% | 217% | IMMU | -59% | -80% | -65% | $0.00 | $0.00 | 0% | 0% | |||||||||||||||||||||||||||||||||||||||||||||
| 1120 | AEZS | Aeterna Zentar | Drug (Biomedical\Genetic) | $ 1.16 | 45% | 2,359,087 | $ 0.15 | -87% | 10% | 26% | -57% | 137% | -68% | AEZS | -0.39 | -0.89 | -1.02 | -0.97 | -149% | -1 | -12 | 5% | -6% | -220% | -2% | -21% | -950% | -6% | 24% | 23% | -23% | 1% | AEZS | 197% | 193% | 39% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1127 | ARNA | Arena Pharm | Drug (Biomedical\Genetic) | $ 5.30 | 45% | 4,049,430 | $ 0.58 | -89% | 0% | 16% | 19% | 27% | -47% | ARNA | -1.69 | -2.35 | -1.81 | -1.37 | 19% | -4 | -12 | 5% | 9% | 80% | -40% | -35% | 13% | 15% | 11% | 10% | 36% | 31% | ARNA | 5% | 39% | 83% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1179 | KDUS | Cadus Pharm | Drug (Biomedical\Genetic) | $ 1.54 | 45% | 89,200 | $ 1.62 | 5% | 6% | 3% | 6% | 14% | -28% | KDUS | -0.04 | -0.04 | -0.1 | -0.10 | -150% | -15 | -12 | -10% | -11% | -10% | 0% | 0% | 0% | 5% | 4% | 5% | 4% | 8% | KDUS | 143% | 251% | 532% | $0.00 | $0.00 | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||
| 1200 | JAZZ | Jazz Pharma | Drug (Ethical) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||